Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Extend Biosciences Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT06988670
- Locations
- 🇦🇷
Trial Site, Buenos Aires, Caba, Argentina
A Phase 1 Study of EXT608 in Healthy Adults
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Extend Biosciences Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05408663
- Locations
- 🇺🇸
PRA, Lenexa, Kansas, United States
News
No news found